Brian M. Frezza is co-founder and co-CEO of Emerald Therapeutics, where he spearheads Emerald’s therapeutic research effort and is the lead architect of the Emerald Cloud Lab (ECL), a web-based platform for remotely conducting and managing data surrounding wet lab experiments. Brian completed his Ph.D. in chemical biology at The Scripps Research Institute (TSRI) working on DNA nanotechnology under committee mentorship of Feynman award-winning chemists M. Reza Ghadiri and Nadrian Seeman. Brian is a Hollerith and Wolfram Innovator award winner who has received over a hundred combined citations for published articles in the Journal of the American Chemical Society (JACS) and Chemical Physics. He has also served as a peer reviewer for both JACS and Langmuir, and guest-lectured at Carnegie Mellon University, TSRI, and Stanford University.
The Next Revolution Will Be Biologized
Wohlsen: As a reporter who’s covered both biotech and what the rest of the world calls just plain “tech,” I can tell you those stories about biology can be tougher to tell. You don’t have the immediate payoff as much, say, as you’d get when you have, you know, an iPhone with a bigger screen, or […]
Conferences
Techonomy 14
This year Techonomy moves to the beautiful Ritz-Carlton Half Moon Bay, November 9-11, on the cliffs south of San Francisco, near Silicon Valley.
